Phase II study of the proteasome inhibitor bortezomib (PS-341, Velcade ®) in chemotherapy-naïve patients with advanced stage non-small cell lung cancer (NSCLC)
| Autor: | Li, Tianhong, Ho, Liawaty, Piperdi, Bilal, Elrafei, Tarek, Camacho, Fernando J., Rigas, James R., Perez-Soler, Roman, Gucalp, Rasim |
|---|---|
| Zdroj: | In Lung Cancer 2010 68(1):89-93 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect